These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis. Cao Y, Zhang F, Wang H, Bi C, Cui J, Liu F, Pan H. Mol Cell Biochem; 2021 Jan 01; 476(1):279-292. PubMed ID: 32965597 [Abstract] [Full Text] [Related]
13. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK. Oncotarget; 2015 Apr 10; 6(10):7899-917. PubMed ID: 25760077 [Abstract] [Full Text] [Related]
14. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy. Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L. Cell Death Dis; 2017 Jan 12; 8(1):e2540. PubMed ID: 28079894 [Abstract] [Full Text] [Related]
15. LncRNA MCM3AP-AS1 Regulates Epidermal Growth Factor Receptor and Autophagy to Promote Hepatocellular Carcinoma Metastasis by Interacting with miR-455. Zhang H, Luo C, Zhang G. DNA Cell Biol; 2019 Aug 12; 38(8):857-864. PubMed ID: 31237446 [Abstract] [Full Text] [Related]